2021
DOI: 10.1891/0730-0832/11-t-675
|View full text |Cite
|
Sign up to set email alerts
|

Early Neurodevelopmental Outcome of Neonates with Gestation 35 Weeks or More with Serum Bilirubin in Exchange Range Without Encephalopathy: A Prospective Observational Study

Abstract: ObjectiveTo describe early neurodevelopment outcomes of neonates with severe hyperbilirubinemia without acute bilirubin encephalopathy (ABE).MethodsNeonates born at gestation ≥35 weeks, admitted to NICU with total serum bilirubin (TSB) in exchange range with no features of ABE, were followed up until the age of 6 months. Infants were assessed for impaired hearing and neurodevelopment at 3 months and 6 months of age.ResultsA total of 59 neonates were enrolled in the study. At 3 months of age, 7.6 percent of neo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Moreover, longitudinal studies have found no consistent correlation between neurologic abnormality and total serum bilirubin level >342 μmol/L. [29][30][31] Studies have documented occurrence of bilirubin-induced neurologic dysfunction at total serum bilirubin levels <342 μmol/L, 32 which may be explained by the fact that the level of indirect bilirubin between 71 and 770 μmol/L may lead to neurotoxicity. 33 Therefore, the sole use of clinical manifestations and total serum bilirubin level for diagnosis of acute bilirubin encephalopathy may lead to treatment delay, increasing the risk of severe neurologic damage.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, longitudinal studies have found no consistent correlation between neurologic abnormality and total serum bilirubin level >342 μmol/L. [29][30][31] Studies have documented occurrence of bilirubin-induced neurologic dysfunction at total serum bilirubin levels <342 μmol/L, 32 which may be explained by the fact that the level of indirect bilirubin between 71 and 770 μmol/L may lead to neurotoxicity. 33 Therefore, the sole use of clinical manifestations and total serum bilirubin level for diagnosis of acute bilirubin encephalopathy may lead to treatment delay, increasing the risk of severe neurologic damage.…”
Section: Discussionmentioning
confidence: 99%